The Feasibility of Introducing a Whole Blood Component for Traumatic Haemorrhage in the UK
| dc.contributor.author | Green, L | en_US |
| dc.date.accessioned | 2024-03-21T11:02:49Z | |
| dc.date.available | 2024-03-19 | en_US |
| dc.date.issued | 2024-04-04 | |
| dc.identifier.issn | 0958-7578 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/95585 | |
| dc.publisher | Wiley | en_US |
| dc.relation.ispartof | Transfusion Medicine | en_US |
| dc.rights | This is the peer reviewed version of the following article: McCullagh J, Basham P, Davies J, et al. The feasibility of introducing a whole blood component for traumatic haemorrhage in the UK. Transfusion Medicine. 2024; 1-7. doi:10.1111/tme.13039, which has been published in final form at 10.1111/tme.13039. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited. | |
| dc.title | The Feasibility of Introducing a Whole Blood Component for Traumatic Haemorrhage in the UK | en_US |
| dc.type | Article | |
| dc.rights.holder | ||
| dc.identifier.doi | 10.1111/tme.13039 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Accepted | en_US |
| dcterms.dateAccepted | 2024-03-19 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| qmul.funder | An evaluation of leucocyte depleted red cells and plasma transfusion for major traumatic haemorrhage in patients presenting to the pre-hospital setting in London (feasibility study), and development of whole blood component for use in future trials.::Barts Charity and London Air Ambulance | en_US |
